Thrombolysis in stroke beyond three hours: Targeting patients with diffusion and perfusion MRI

被引：45

作者：

Warach, S ^{[1
]}

机构：

[1] NINCDS, Bethesda, MD 20892 USA

来源：

ANNALS OF NEUROLOGY | 2002年 / 51卷 / 01期

关键词：

D O I：

10.1002/ana.10109

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：11 / 13

页数：3

共 14 条

[1] Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging [J].

Baird, AE ;

Benfield, A ;

Schlaug, G ;

Siewert, B ;

Lovblad, KO ;

Edelman, RR ;

Warach, S .

ANNALS OF NEUROLOGY, 1997, 41 (05) :581-589

[2] Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset - The ATLANTIS study: A randomized controlled trial [J].

Clark, WM ;

Wissman, S ;

Albers, GW ;

Jhamandas, JH ;

Madden, KP ;

Hamilton, S .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (21) :2019-2026

[3] Diffusion-weighted MR imaging:: Diagnostic accuracy in patients imaged within 6 hours of stroke symptom onset [J].

González, RG ;

Schaefer, PW ;

Buonanno, FS ;

Schwamm, LH ;

Budzik, RF ;

Rordorf, G ;

Wang, B ;

Sorensen, AG ;

Koroshetz, WJ .

RADIOLOGY, 1999, 210 (01) :155-162

[4] Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) [J].

Hacke, W ;

Kaste, M ;

Fieschi, C ;

von Kummer, R ;

Davalos, A ;

Meier, D ;

Larrue, V ;

Bluhmki, E ;

Davis, S ;

Donnan, G ;

Schneider, D ;

Diez-Tejedor, E ;

Trouillas, P .

LANCET, 1998, 352 (9136) :1245-1251

[5]

HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017

[6] Evaluation of early reperfusion and IV tPA therapy using diffusion- and perfusion-weighted MRI [J].

Marks, MP ;

Tong, DC ;

Beaulieu, C ;

Albers, GW ;

de Crespigny, A ;

Moseley, ME .

NEUROLOGY, 1999, 52 (09) :1792-1798

[7] TISSUE-PLASMINOGEN ACTIVATOR FOR ACUTE ISCHEMIC STROKE [J].

MARLER, JR ;

BROTT, T ;

BRODERICK, J ;

KOTHARI, R ;

ODONOGHUE, M ;

BARSAN, W ;

TOMSICK, T ;

SPILKER, J ;

MILLER, R ;

SAUERBECK, L ;

JARRELL, J ;

KELLY, J ;

PERKINS, T ;

MCDONALD, T ;

RORICK, M ;

HICKEY, C ;

ARMITAGE, J ;

PERRY, C ;

THALINGER, K ;

RHUDE, R ;

SCHILL, J ;

BECKER, PS ;

HEATH, RS ;

ADAMS, D ;

REED, R ;

KLEI, M ;

HUGHES, S ;

ANTHONY, J ;

BAUDENDISTEL, D ;

ZADICOFF, C ;

RYMER, M ;

BETTINGER, I ;

LAUBINGER, P ;

SCHMERLER, M ;

MEIROSE, G ;

LYDEN, P ;

RAPP, K ;

BABCOCK, T ;

DAUM, P ;

PERSONA, D ;

BRODY, M ;

JACKSON, C ;

LEWIS, S ;

LISS, J ;

MAHDAVI, Z ;

ROTHROCK, J ;

TOM, T ;

ZWEIFLER, R ;

DUNFORD, J ;

ZIVIN, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (24) :1581-1587

[8] Early stroke treatment associated with better outcome - The NINDS rt-PA Stroke Study [J].

Marler, JR ;

Tilley, BC ;

Lu, M ;

Brott, TG ;

Lyden, PC ;

Grotta, JC ;

Broderick, JP ;

Levine, SR ;

Frankel, MP ;

Horowitz, SH ;

Haley, EC ;

Lewandowski, CA ;

Kwiatkowski, TP .

NEUROLOGY, 2000, 55 (11) :1649-1655

[9] Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke [J].

Parsons, MW ;

Barber, PA ;

Chalk, J ;

Darby, DG ;

Rose, S ;

Desmond, PM ;

Gerraty, RP ;

Tress, BM ;

Wright, PM ;

Donnan, GA ;

Davis, SM .

ANNALS OF NEUROLOGY, 2002, 51 (01) :28-37

[10] Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI [J].

Schellinger, PD ;

Jansen, O ;

Fiebach, JB ;

Heiland, S ;

Steiner, T ;

Schwab, SF ;

Pohlers, O ;

Ryssel, H ;

Sartor, K ;

Hacke, W .

STROKE, 2000, 31 (06) :1318-1328

← 1 2 →